Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Magellan Health's Arm Expands Its Suite Of Health Solutions

Published 01/05/2020, 09:52 PM
Updated 07/09/2023, 06:31 AM

Magellan Health, Inc. (NASDAQ:MGLN) has announced that its unit Magellan Complete Care of Virginia extended its range of current offerings to provide Medicare Advantage Dual Special Needs Plan (D-SNP) for 2020.

This project is specially designed for individuals eligible for Medicare and Medicaid in Virginia. With this new offering, the company expects to enhance the quality of life, health and safety of MCC of VA members.

The company’s array of new services managing physical health, behavioral health, pharmacy benefits and other requisites would likely lead to better health outcomes. This convenient, one-stop D-SNP solution is also projected to solve complex health conditions of patients.

The strategic move is in line with the company's commitment to cater to individuals with special healthcare needs.

Prospects of Medicare Advantage Business

Medicare is now the fastest-evolving business in the health insurance market, holding ample potential. With 10,000 baby boomers aging into the program every day, the Trump administration expects this business to thrive 10% this year.

As more and more people are looking for value-based care at affordable costs, health insurers seize this opportunity to quickly draw up some feasible plans to cater to this increasing demand. For example, Humana Inc (NYSE:HUM) recently entered into a partnership with Hawaii Senior Medical Group to offer a coordinated and enriched experience for Medicare Advantage members in Hawaii. The entity is also chosen as one of the health plans to provide Florida’s Medicare retirees with Medicare coverage effective Jan 1, 2020.

Other companies, such as Centene Corporation (NYSE:CNC) and Anthem, Inc. (NYSE:ANTM) are also taking up strategic initiatives to boost their respective Medicare businesses.

Shares of this Zacks Rank #4 (Sell) player have gained 26.7% in a year’s time, outperforming its industry’s growth of 20.6%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.



More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Anthem, Inc. (ANTM): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Magellan Health, Inc. (MGLN): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.